Menumenu
  • slide

    Current practice insights into the use of biologicals

  • slide

    Rapid access to our in-house patient-centric Database Network

  • slide

    An experienced sparring partner for your European healthcare questions

  • slide

    Dedicated to research real-life health care for the benefit of patients

  • News

    PHARMO Magazine

    We are proud to offer you the first edition of our new and improved PHARMO Magazine. In this online magazine you can read about our research, our collaborations with universities and other research institutions and upcoming events. Through our st...

    PHARMO’s annual scientific report 2018 available

    PHARMO's annual scientific report discusses the current expertise and research of the PHARMO Institute, publications, international collaborations and partners. Furthermore the annual report describes the organisational structure and information on h...

    Comparable paediatric safety profiles of proton pump inhibitors and histamine-2 receptor antagonists

    Hospitalisation rates for predefined safety outcomes (gastroenteritis, convulsion/seizure, pneumonia, thrombocytopenia, acute interstitial nephritis, angioneurotic oedema and failure to thrive) were low and mostly similar in paediatric first-time use...

  • Events

  • Vacancy

    MANAGER VAN DE PHARMO ONDERZOEKSGROEP

    MANAGER VAN DE PHARMO ONDERZOEKSGROEP Wil je bijdragen aan meer transparantie in de gezondheidszorg? Heb je een onderzoekshart en een zakelijke instelling? Ben jij een leider die je team inspireert en helpt om nieuwe hoogten te bereiken? En duik je ...

    (Senior) Global Account Manager (Locatie Utrecht)

    (SENIOR) GLOBAL ACCOUNT MANAGER (LOCATIE UTRECHT) Om het aantal onderzoeksprojecten te verhogen, is het PHARMO Instituut op zoek naar een Senior Global Account Manager om zich te concentreren op de internationale markt. Bij PHARMO doen we onderzo...

  • icon

    What we do

    As an independent research organisation dedicated to the study of epidemiology, drug utilisation, drug safety, health outcomes, and utilisation of healthcare resources PHARMO assists its clients in their decision-making.

  • icon

    What we have

    PHARMO Database Network: we have rapid access to our rich population-based network of databases. Data are derived from different primary and secondary healthcare settings. For our observational studies disease-specific cohorts are created from the various databases.

Publications

  • Chemotherapy for ovarian cancer in the Netherlands: a population-based study on treatment patterns and outcomes

    Read more
  • Patterns of antiplatelet drug use after a first myocardial infarction during a 10-year period

    Read more
  • No decreased risk of gastrointestinal cancers in users of metformin in The Netherlands; a time-varying analysis of metformin exposure

    Read more
  • Antipsychotic drug use associated with urinary tract infections in older women

    Read more